Chimeric Antigen Receptor News and Research

RSS
Asimov Launches LV Edge Packaging System to Optimize Lentivirus Production

Asimov Launches LV Edge Packaging System to Optimize Lentivirus Production

Researchers Enhance CAR-T Cell Therapy by Preventing T-Cell Exhaustion

Researchers Enhance CAR-T Cell Therapy by Preventing T-Cell Exhaustion

Lactate Oxidase Nanocapsules Help the Immune System to Fight and Kill Solid Tumors

Lactate Oxidase Nanocapsules Help the Immune System to Fight and Kill Solid Tumors

Effectiveness of SCID-X1 Gene Therapy Influenced by 3D Genome Architecture

Effectiveness of SCID-X1 Gene Therapy Influenced by 3D Genome Architecture

New CAR T Strategy Offers a Dual-Targeting Mechanism to Fight Bone Metastatic Prostate Cancer

New CAR T Strategy Offers a Dual-Targeting Mechanism to Fight Bone Metastatic Prostate Cancer

New Approach Could Power the Development of Advanced Cell Therapies

New Approach Could Power the Development of Advanced Cell Therapies

High-Throughput Assay to Analyze the Effects of CAR-T Cells Using Image Cytometry

High-Throughput Assay to Analyze the Effects of CAR-T Cells Using Image Cytometry

New study pinpoints key source of T cell "exhaustion"

New study pinpoints key source of T cell "exhaustion"

Gut microbiome may modulate the efficacy of CAR-T cell cancer immunotherapy

Gut microbiome may modulate the efficacy of CAR-T cell cancer immunotherapy

Understanding the relationship between gut microbiome and CAR T-cell therapy response

Understanding the relationship between gut microbiome and CAR T-cell therapy response

MD Anderson and Replay launch new company pioneering T cell receptor NK cell therapies

MD Anderson and Replay launch new company pioneering T cell receptor NK cell therapies

Treating ovarian cancer with immunotherapy involving CAR T cells

Treating ovarian cancer with immunotherapy involving CAR T cells

CAR T-cell therapy effective in mice with ovarian cancer

CAR T-cell therapy effective in mice with ovarian cancer

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Novel adoptive T cell receptor therapy shows promising results for patients with solid tumors

Novel blood biomarker predicts a favorable response to CART cell therapy

Novel blood biomarker predicts a favorable response to CART cell therapy

Improving cancer immunotherapies with bioengineered synthetic gene circuits

Improving cancer immunotherapies with bioengineered synthetic gene circuits

Researchers find immune-effective ways to destroy cancer cells

Researchers find immune-effective ways to destroy cancer cells

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

Researchers discover a new interferon-gamma receptor signaling pathway

Researchers discover a new interferon-gamma receptor signaling pathway

Study shows new potential target for CAR T cells to inhibit solid tumors

Study shows new potential target for CAR T cells to inhibit solid tumors

Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.